Literature DB >> 22419806

The amino terminus of the vaccinia virus E3 protein is necessary to inhibit the interferon response.

Stacy D White1, Bertram L Jacobs.   

Abstract

Vaccinia virus (VACV) encodes a multifunctional protein, E3L, that is necessary for interferon (IFN) resistance in cells in culture. Interferon resistance has been mapped to the well-characterized carboxy terminus of E3L, which contains a conserved double-stranded RNA binding domain. The amino terminus of E3L has a Z-form nucleic acid binding domain, which has been shown to be dispensable for replication and IFN resistance in HeLa and RK13 cells; however, a virus expressing E3L deleted of the amino terminus has reduced pathogenicity in an animal model. In this study, we demonstrate that the pathogenicity of a virus expressing E3L deleted of the amino terminus was fully rescued in type I IFN receptor knockout (IFN-α/βR(-/-)) mice. Furthermore, this virus was IFN sensitive in primary mouse embryo fibroblasts (MEFs). This virus induced the phosphorylation of the α subunit of eukaryotic initiation factor 2 (eIF2α) in MEFs in an IFN-dependent manner. The depletion of double-stranded RNA-dependent protein kinase (PKR) from these MEFs restored the IFN resistance of this virus. Furthermore, the virus expressing E3L deleted of the amino terminus was also IFN resistant in PKR(-/-) MEFs. Thus, our data demonstrate that the amino terminus of E3L is necessary to inhibit the type I IFN response both in mice and in MEFs and that in MEFs, the amino terminus of E3L functions to inhibit the PKR pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22419806      PMCID: PMC3347311          DOI: 10.1128/JVI.06889-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  A PKR-like eukaryotic initiation factor 2alpha kinase from zebrafish contains Z-DNA binding domains instead of dsRNA binding domains.

Authors:  Stefan Rothenburg; Nikolaus Deigendesch; Katharina Dittmar; Friedrich Koch-Nolte; Friedrich Haag; Ky Lowenhaupt; Alexander Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-19       Impact factor: 11.205

2.  Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.

Authors:  Ping Zhang; Bertram L Jacobs; Charles E Samuel
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

3.  The Atlantic salmon Z-DNA binding protein kinase phosphorylates translation initiation factor 2 alpha and constitutes a unique orthologue to the mammalian dsRNA-activated protein kinase R.

Authors:  Veronica Bergan; Rosemary Jagus; Silje Lauksund; Øyvind Kileng; Børre Robertsen
Journal:  FEBS J       Date:  2007-12-11       Impact factor: 5.542

4.  The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response.

Authors:  Teresa Brandt; Michael C Heck; Sangeetha Vijaysri; Garilyn M Jentarra; Jason M Cameron; Bertram L Jacobs
Journal:  Virology       Date:  2005-03-15       Impact factor: 3.616

5.  PKR and GCN2 kinases and guanine nucleotide exchange factor eukaryotic translation initiation factor 2B (eIF2B) recognize overlapping surfaces on eIF2alpha.

Authors:  Madhusudan Dey; Bruce Trieselmann; Emily G Locke; Jingfang Lu; Chune Cao; Arvin C Dar; Thanuja Krishnamoorthy; Jinsheng Dong; Frank Sicheri; Thomas E Dever
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  The interaction between Z-DNA and the Zab domain of double-stranded RNA adenosine deaminase characterized using fusion nucleases.

Authors:  Y G Kim; K Lowenhaupt; T Schwartz; A Rich
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

Review 7.  The dsRNA protein kinase PKR: virus and cell control.

Authors:  M A García; E F Meurs; M Esteban
Journal:  Biochimie       Date:  2007-03-12       Impact factor: 4.079

8.  Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.

Authors:  Sangeetha Vijaysri; Garilyn Jentarra; Michael C Heck; Andrew A Mercer; Colin J McInnes; Bertram L Jacobs
Journal:  Vaccine       Date:  2007-12-04       Impact factor: 3.641

9.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response.

Authors:  Akinori Takaoka; Zhichao Wang; Myoung Kwon Choi; Hideyuki Yanai; Hideo Negishi; Tatsuma Ban; Yan Lu; Makoto Miyagishi; Tatsuhiko Kodama; Kenya Honda; Yusuke Ohba; Tadatsugu Taniguchi
Journal:  Nature       Date:  2007-07-08       Impact factor: 49.962

Review 10.  Interferons at age 50: past, current and future impact on biomedicine.

Authors:  Ernest C Borden; Ganes C Sen; Gilles Uze; Robert H Silverman; Richard M Ransohoff; Graham R Foster; George R Stark
Journal:  Nat Rev Drug Discov       Date:  2007-12       Impact factor: 84.694

View more
  23 in total

1.  The Structure of the Cyprinid herpesvirus 3 ORF112-Zα·Z-DNA Complex Reveals a Mechanism of Nucleic Acids Recognition Conserved with E3L, a Poxvirus Inhibitor of Interferon Response.

Authors:  Krzysztof Kuś; Krzysztof Rakus; Maxime Boutier; Theokliti Tsigkri; Luisa Gabriel; Alain Vanderplasschen; Alekos Athanasiadis
Journal:  J Biol Chem       Date:  2015-11-11       Impact factor: 5.157

2.  Crystal structure of a poxvirus-like zalpha domain from cyprinid herpesvirus 3.

Authors:  Ana Rita Tomé; Krzysztof Kuś; Silvia Correia; Lara Martins Paulo; Sónia Zacarias; Matteo de Rosa; Delio Figueiredo; R Michael E Parkhouse; Alekos Athanasiadis
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

3.  Mutational analysis of vaccinia virus E3 protein: the biological functions do not correlate with its biochemical capacity to bind double-stranded RNA.

Authors:  Kevin J Dueck; YuanShen Sandy Hu; Peter Chen; Yvon Deschambault; Jocelyn Lee; Jessie Varga; Jingxin Cao
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.

Authors:  Ruikang Liu; Bernard Moss
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

5.  Functional analysis of the short isoform of orf virus protein OV20.0.

Authors:  Yeu-Yang Tseng; Fong-Yuan Lin; Sun-Fang Cheng; David Tscharke; Songkhla Chulakasian; Chia-Chi Chou; Ya-Fen Liu; Wei-Shan Chang; Min-Liang Wong; Wei-Li Hsu
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

6.  Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.

Authors:  William D Arndt; Stacy D White; Brian P Johnson; Trung Huynh; Jeffrey Liao; Heather Harrington; Samantha Cotsmire; Karen V Kibler; Jeffrey Langland; Bertram L Jacobs
Journal:  Virology       Date:  2016-07-26       Impact factor: 3.616

7.  Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1.

Authors:  Craig J Bierle; Kathryn M Semmens; Adam P Geballe
Journal:  Virology       Date:  2013-04-17       Impact factor: 3.616

8.  Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.

Authors:  Heather Koehler; Samantha Cotsmire; Jeffrey Langland; Karen V Kibler; Daniel Kalman; Jason W Upton; Edward S Mocarski; Bertram L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

9.  Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.

Authors:  William D Arndt; Samantha Cotsmire; Kelly Trainor; Heather Harrington; Kevin Hauns; Karen V Kibler; Trung P Huynh; Bertram L Jacobs
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

Review 10.  Translational Control in Virus-Infected Cells.

Authors:  Noam Stern-Ginossar; Sunnie R Thompson; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.